Dydrogesterone (duphaston) and its 20-dihydro- metabolite as selective modulators of estrogenic enzymes in human breast cancer cells
Н. Н. Thole , G. S. Chetrite , G. S. Philippe , J. R. Pasqualini
Journal of obstetrics and women's diseases ›› 2005, Vol. 54 ›› Issue (2) : 67 -72.
Dydrogesterone (duphaston) and its 20-dihydro- metabolite as selective modulators of estrogenic enzymes in human breast cancer cells
The presented data open up interesting prospects for studying the biological responses of progestogens in clinical trials in patients with breast cancer. Estradiol is one of the main factors that control the growth and development of breast cancer. Therefore, an important goal of research in recent years is to block the formation of estradiol inside cancer cells.
dydrogesterone / progestogens / breast cancer cells / sulfatase / 17 β —hydrosteroid — dehydrogenase
| [1] |
Abdul—Hajj Y.J., Iverson R. and Kiang D.T.// Steroids 33:205—222, 1978. |
| [2] |
Perel E., Wilkins D. and Killinger D. W. // J. Steroid Biochem13: 89—94,1980. |
| [3] |
Vignon F., Terqui M., Wesstley B. et al. //Endocrinology106:1079—1086,1980. |
| [4] |
Pasqualini J.R., Geliy C. and Lecerf F. // Breast CancerRes.Treat 8: 233—240,1986. |
| [5] |
Mac Indoc J.R. with the technical assistance of Woods G., Jeffries L. and Hinkhouse M. //Endocrinology 123:1281— 1287,1988. |
| [6] |
Abdul—Hajj Y.J., Iverson R. and Kiang D.T. // Steroids 33: 477—484, 1979. |
| [7] |
Bonney R.C., Reed M.J. Davidson K. et al. // Clin. Endocr. 19:727—739,1983. |
| [8] |
McNeil J.M., Reed M.J., Beranek P.A. et al. // Int. J. Cancer 38:193—196,1986. |
| [9] |
Pasqualini J.R., Chetrite G., Blacker C. et al. // J. Clin.Endocr. Metab. 81:1460—1464,1996. |
| [10] |
Chetrite G., Cortes—Priento J., Philippe J—C. et al. // J. Steroid. Biochem. Molec. Biol. 72: 23—27, 2000. |
| [11] |
Santner S.J., Feil P.D. and Santen R.J. // J. Clin. Endocr.Metab. 59: 29—33,1984. |
| [12] |
Dao T.L., Libby P.R. // J. Clin. Endocr. 28: 1431—1439, 1968. |
| [13] |
Tseng L., Mazella J., Lee L.Y. and Stone M.L. // J.Steroid. Biochem. 19: 1413—1417, 1983. |
| [14] |
Pasqualini J.R. // Eur. J. Cancer 28A: 758—762.1992. |
| [15] |
Burton K. // Biochem. J. 62: 315—323.1956. |
| [16] |
Brodie A.M.H., et al. // J. Steroid. Biochem. 24: 91—97,1986. |
| [17] |
de Jong P C., et al. //Cancer Res. 57: 2109—2111,1997. |
| [18] |
Poutanen M., Moncharmont B. and Vihko R. //Cancer Res. 52: 290—294,1992. |
| [19] |
McNeil J.M., Reed M.J., Beranek P.A. et al. // Int. J. Cancer 38:193—196,1986. |
| [20] |
Couture P., Theriault C., Simard J. and Labrie F. // Endocrinology 132:179—185,1993. |
| [21] |
Nguyen B—L., Chetrite G. and Pasqualini J.R. // Breast Cancer Res. Treat 34:139—146,1995. |
| [22] |
Peltoketo H., et al. //J. Endocr. 150: S21—S30,1996. |
Eсо-Vector
/
| 〈 |
|
〉 |
PDF
